Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors

PHASE2TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Stomach Neoplasms
Interventions
DRUG

AMG 337

AMG 337 300mg orally daily.

Trial Locations (97)

1000

Research Site, Brussels

1070

Research Site, Brussels

1097

Research Site, Budapest

2050

Research Site, Camperdown

2650

Research Site, Edegem

3000

Research Site, Leuven

3084

Research Site, Heidelberg

3165

Research Site, Bentleigh East

4000

Research Site, Liège

4010

Research Site, Linz

4032

Research Site, Debrecen

4600

Research Site, Wels

5004

Research Site, Szolnok

5020

Research Site, Salzburg

5037

Research Site, Kurralta Park

6000

Research Site, Charleroi

6020

Research Site, Innsbruck

7400

Research Site, Kaposvár

9000

Research Site, Ghent

10021

Research Site, New York

10065

Research Site, New York

10126

Research Site, Torino

10467

Research Site, The Bronx

11527

Research Site, Athens

11528

Research Site, Athens

13385

Research Site, Marseille

14564

Research Site, Athens

14642

Research Site, Rochester

16132

Research Site, Genova

18537

Research Site, Piraeus

20089

Research Site, Rozzano MI

20133

Research Site, Milan

20162

Research Site, Milan

25123

Research Site, Brescia

26100

Research Site, Cremona

28034

Research Site, Madrid

28040

Research Site, Madrid

28041

Research Site, Madrid

29010

Research Site, Málaga

33075

Research Site, Bordeaux

33100

Research Site, Udine

40138

Research Site, Bologna

41013

Research Site, Seville

43126

Research Site, Parma

44106

Research Site, Cleveland

44800

Research Site, Saint-Herblain

45500

Research Site, Ioannina

49933

Research Site, Angers

50134

Research Site, Florence

50937

Research Site, Cologne

51092

Research Site, Reims

55131

Research Site, Mainz

56126

Research Site, Pisa

59020

Research Site, Lille

60126

Research Site, Ancona

69373

Research Site, Lyon

71110

Research Site, Heraklion - Crete

80131

Research Site, Napoli

81675

Research Site, München

94805

Research Site, Villejuif

98109

Research Site, Seattle

115478

Research Site, Moscow

119991

Research Site, Moscow

197758

Research Site, Saint Petersburg

350040

Research Site, Krasnodar

7500921

Research Site, Santiago

7630370

Research Site, Santiago

8420383

Research Site, Santiago

06520

Research Site, New Haven

T6G 1Z2

Research Site, Edmonton

500 05

Research Site, Hradec Králové

775 20

Research Site, Olomouc

120 00

Research Site, Prague

04103

Research Site, Leipzig

00189

Research Site, Roma

Lima 11

Research Site, Lima

Lima 18

Research Site, Lima

15-027

Research Site, Bialystok

82-300

Research Site, Elblag

62-500

Research Site, Konin

93-513

Research Site, Lodz

02-781

Research Site, Warsaw

410-769

Research Site, Goyang-si, Gyeonggi-do

519-763

Research Site, Hwasun

110-744

Research Site, Seoul

120-752

Research Site, Seoul

135-710

Research Site, Seoul

137-701

Research Site, Seoul

138-736

Research Site, Seoul

08035

Research Site, Barcelona

08036

Research Site, Barcelona

EH4 2XU

Research Site, Edinburgh

LE1 5WW

Research Site, Leicester

SE1 7EH

Research Site, London

M20 4BX

Research Site, Manchester

HA6 2RN

Research Site, Northwood

SM2 5PT

Research Site, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY